European Society of Cardiology

Related Content

More than 30,271 health professionals from 174 countries attended this year’s event, which covered the entire field of cardiovascular medicine at ESC22
News | ESC
Best of ESC Congress 2022

September 1, 2022 — “At ESC Congress in Barcelona, we discussed the newest science in the light of our collective ...

Home September 01, 2022
arrow
Comatose patients admitted to hospital after resuscitation from out-of-hospital cardiac arrest have a significant risk of death and poor neurological outcome due to hypoxic brain injury.
News | Sudden Cardiac Arrest
Trial Finds no Benefit of Raising Blood Pressure Target in Post Cardiac Arrest Patients

September 1, 2022 — A target blood pressure of 77 mmHg provides no benefit to survival or neurological outcome in ...

Home September 01, 2022
arrow
ALL-HEART trial presented in a Hot Line Session at ESC Congress 2022
News | Stroke
Allopurinol Does Not Improve Cardiovascular Outcomes in Ischaemic Heart Disease Patients

September 1, 2022 — The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial ...

Home September 01, 2022
arrow
Pesticides and heavy metals in soil may have detrimental effects on the cardiovascular system, according to a review paper published today in Cardiovascular Research
News | Heart Failure
Scientists Warn of Links Between Soil Pollution and Heart Disease

July 12, 2022 — Pesticides and heavy metals in soil may have detrimental effects on the cardiovascular system, according ...

Home July 12, 2022
arrow
Eating low glycaemic index foods promotes a healthier body shape in patients with coronary artery disease, according to a study presented at ACNAP-EuroHeartCare Congress 2022, a scientific congress of the European Society of Cardiology (ESC).
News | ESC
Low Glycaemic Index Diet Helps Heart Patients Lose Weight

June 1, 2022 — Eating low glycaemic index foods promotes a healthier body shape in patients with coronary artery disease ...

Home June 01, 2022
arrow
Recardio Inc., a late stage clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the FDA concurs with Recardio's pivotal Heal-MI Phase 3 trial design with Dutogliptin in Acute Myocardial Infarction
News | Cardiogenic Shock
Recardio and FDA Reach Agreement on Pivotal Phase 3 Trial Design

June 1, 2022 — Recardio's Phase 2 trial results demonstrated the excellent safety profile of its lead drug Dutogliptin ...

Home June 01, 2022
arrow
First clinical data of implantable heart sensor with remote measurement capabilities presented at prestigious Late-Breaking Science forum at the ESC Heart Failure 2022
News | Heart Failure
VECTOR-HF I Study Confirms Safety and Accuracy of V-LAP In-Heart Sensor for Left Atrial Pressure Management of Heart Failure

May 31, 2022 — Vectorious Medical Technologies Ltd., an innovator in implantable hemodynamic monitoring in heart failure ...

Home May 31, 2022
arrow
Late-breaking results presented at the European Society of Cardiology's Heart Failure Association annual conference and simultaneously published online in the European Journal of Heart Failure
News | Heart Failure
Axon Therapies Announces Positive Early Clinical Data from REBALANCE-HF Randomized Clinical Trial

May 26, 2022 — Axon Therapies, a private company focused on addressing a root cause of heart failure, today announced ...

Home May 26, 2022
arrow
Heart failure presents differently in women and men – discover the latest evidence and its impact on management at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).
News | ESC
Improving Outcomes for all Patients with Heart Failure

May 9, 2022 — Heart failure presents differently in women and men – discover the latest evidence and its impact on ...

Home May 09, 2022
arrow
A small study has shown that SARS-CoV-2 vaccination in patients who had an inflamed heart muscle in the past is not associated with a recurrence of the condition or other serious side effects.
News | Coronavirus (COVID-19)
Study: COVID-19 Vaccination is Safe in Patients with Previous Myocarditis

March 22, 2022 — A small study has shown that SARS-CoV-2 vaccination in patients who had an inflamed heart muscle in the ...

Home March 22, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now